83 related articles for article (PubMed ID: 9883763)
21. [Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
Mal' GS
Klin Med (Mosk); 2004; 82(5):63-6. PubMed ID: 15230046
[TBL] [Abstract][Full Text] [Related]
22. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
Sterna R
Ann Acad Med Stetin; 1997; 43():67-77. PubMed ID: 9471924
[TBL] [Abstract][Full Text] [Related]
23. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
24. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
[TBL] [Abstract][Full Text] [Related]
25. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients.
Venkiteswaran K; Sgoutas DS; Santanam N; Neylan JF
Transpl Int; 2001 Dec; 14(6):405-10. PubMed ID: 11793038
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
28. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
[TBL] [Abstract][Full Text] [Related]
29. Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment.
Malminiemi K; Palomäki A; Malminiemi O
Free Radic Res; 2000 Nov; 33(5):581-93. PubMed ID: 11200090
[TBL] [Abstract][Full Text] [Related]
30. Bezafibrate and serum amyloid A--low-density lipoprotein complex in patients with type 2 diabetes mellitus and hypertriglyceridemia.
Kotani K; Satoh N; Yamada T
Eur J Intern Med; 2010 Apr; 21(2):e10. PubMed ID: 20206863
[No Abstract] [Full Text] [Related]
31. Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonate.
Beil FU; Schrameyer-Wernecke A; Beisiegel U; Greten H; Karkas JD; Liou R; Alberts AW; Eckardt HG; Till AE
Cardiology; 1990; 77 Suppl 4():22-32. PubMed ID: 2073669
[TBL] [Abstract][Full Text] [Related]
32. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
33. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
[TBL] [Abstract][Full Text] [Related]
35. Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men.
Hernández C; Lecube A; Barberá G; Chacón P; Lima J; Simó R
Med Sci Monit; 2003 Mar; 9(3):CR114-9. PubMed ID: 12640339
[TBL] [Abstract][Full Text] [Related]
36. Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients.
Perez-Jimenez F; Hidalgo L; Zambrana JL; Arizon JM; Jimenez-Pereperez JA; Concha M; Espino A; Blanco J; Valles F; Lopez-Miranda J
Am J Cardiol; 1995 Mar; 75(8):648-50. PubMed ID: 7887403
[TBL] [Abstract][Full Text] [Related]
37. [Lipid lowering: myth or therapeutic necessity?].
Dtsch Med Wochenschr; 1998 Oct; 123(40 Suppl):2-8. PubMed ID: 9793486
[No Abstract] [Full Text] [Related]
38. Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation.
Palomäki A; Malminiemi K; Malminiemi O; Solakivi T
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1541-8. PubMed ID: 10364087
[TBL] [Abstract][Full Text] [Related]
39. Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients.
Barbir M; Hunt B; Kushwaha S; Kehely A; Prescot R; Thompson GR; Mitchell A; Yacoub M
Am J Cardiol; 1992 Dec; 70(20):1596-601. PubMed ID: 1466329
[TBL] [Abstract][Full Text] [Related]
40. [Flotation mass-spectra and surface potential of low density lipoprotein particles of hyperlipidemic patients after forced abolishment of lavostatin treatment].
Morozkin AD; Sumarokov AB; Medvedeva NV; Liakishev AA
Biomed Khim; 2003; 49(6):566-75. PubMed ID: 16119085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
